Statin use and development and progression of non-alcohol fatty liver disease based on ultrasonography: a cohort study.

Baoyu FengFengde LiYanqi LanXiaomo WangShuohua ChenChenlu YangMeihua YinFeipeng CuiGuodong WangDi ZhouYang ZhouShutong WuLi WangShouling Wu

Published in: The Journal of clinical endocrinology and metabolism (2024)

Taking statin may decrease the risk of NAFLD occurrence and progression in the population with statin indication, suggesting the potential role of statin in both primary and secondary prevention strategies for NAFLD, especially among those with low or moderate ASCVD risk.

Keyphrases

cardiovascular disease
coronary artery disease
low density lipoprotein
magnetic resonance imaging
risk assessment
high intensity
computed tomography
alcohol consumption